SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-24-007125
Filing Date
2024-04-19
Accepted
2024-04-18 20:24:28
Documents
133
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 bp41224620f.htm   iXBRL 20-F 3633141
2 EXHIBIT 2.1 ex2_1.htm EX-2.1 265687
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 214274
4 EXHIBIT 8.1 ex8_1.htm EX-8.1 8419
5 EXHIBIT 12.1 ex12_1.htm EX-12.1 9391
6 EXHIBIT 13.1 ex13_1.htm EX-13.1 4755
7 EXHIBIT 15.1 ex15_1.htm EX-15.1 5867
8 EXHIBIT 97.1 ex97_1.htm EX-97.1 31056
14 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
15 GRAPHIC pipeline.jpg GRAPHIC 91141
  Complete submission text file 0001214659-24-007125.txt   15450352

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE bdrx-20231231.xsd EX-101.SCH 115422
10 XBRL CALCULATION FILE bdrx-20231231_cal.xml EX-101.CAL 75128
11 XBRL DEFINITION FILE bdrx-20231231_def.xml EX-101.DEF 270874
12 XBRL LABEL FILE bdrx-20231231_lab.xml EX-101.LAB 480554
13 XBRL PRESENTATION FILE bdrx-20231231_pre.xml EX-101.PRE 437216
136 EXTRACTED XBRL INSTANCE DOCUMENT bp41224620f_htm.xml XML 3573846
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37652 | Film No.: 24855379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)